Israel is a first year Molecular and Cellular Life Sciences Master student. He has a strong background in cancer research and a keen interest in cancer prevention. Isarel’s bachelor thesis focused on reducing the side-effects of Cisplatin (a chemotherapeutic drug used to treat prostate cancer) by antagonising the RAR-Beta receptor. He is currently preparing his master dissertation at the Center for Structural Biology in Brussels on the topic of ‘Development of fluorescent biosensors to identify new drug targets in cancer’. Israel firmly believes that we cannot treat our way out of the cancer problem. A balanced approach to prevention, early detection and treatment is required.